681 Clinical trials in hidradenitis suppurativa and psoriasis under-represent certain gender, ethnic, and racial groups

Abstract

Hidradenitis suppurativa (HS) and psoriasis (PsO) are inflammatory skin conditions with distinct demographic profiles. We sought to determine whether gender, ethnic, and racial profiles of clinical trial patients match those of HS and PsO populations, although it is unknown whether demographics change treatment response. We identified completed phase II-III clinical trials starting after January 1, 2010 from the US National Library of Medicine (ClinicalTrials.gov) on systemic therapies for HS and PsO in adults.